Continuous bioprocessing is a hot topic in the biopharmaceutical industry today. Despite the many hurdles to implementing Next Generation Bioprocessing, many companies both large and small are starting to make the switch in order to reap benefits such as productivity gains, elimination of capacity constraints, increased flexibility and reduction in cost. In this supplement, experts from biologics manufacturers and MilliporeSigma provide a background on Next Generation Bioprocessing and give perspectives on the on-going paradigm shift for the current and future biopharma landscape.
Please check the highlighted fields and try again.
Please enter your first and last name.
Please enter the name of the company or institution you work at.
Please enter your mailing address.
Please enter the e-mail address you would like to be contacted at.
Please enter the phone number you would like to be contacted at.